5 Health Services Stocks On The Rise

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 15 points (0.1%) at 16,035 as of Monday, Dec. 9, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,480 issues advancing vs. 1,397 declining with 175 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Given Imaging ( GIVN), up 25.8%, DaVita HealthCare Partners ( DVA), up 4.3%, Parexel International Corporation ( PRXL), up 4.2%, Grifols ( GRFS), up 0.9% and Humana ( HUM), up 0.7%. A company within the industry that fell today was Centene Corporation ( CNC), up 2.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Cigna ( CI) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $1.00 (1.2%) to $87.50 on average volume. Thus far, 671,369 shares of Cigna exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $87.21-$87.93 after having opened the day at $87.51 as compared to the previous trading day's close of $86.50.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $23.3 billion and is part of the health care sector. The company has a P/E ratio of 12.8, below the S&P 500 P/E ratio of 17.7. Shares are up 57.7% year to date as of the close of trading on Friday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Aetna ( AET) is up $0.57 (0.9%) to $66.59 on light volume. Thus far, 784,614 shares of Aetna exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $66.08-$66.74 after having opened the day at $66.25 as compared to the previous trading day's close of $66.02.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $23.8 billion and is part of the health care sector. The company has a P/E ratio of 13.2, below the S&P 500 P/E ratio of 17.7. Shares are up 42.6% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, WellPoint ( WLP) is up $0.92 (1.0%) to $91.61 on light volume. Thus far, 539,687 shares of WellPoint exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $90.86-$91.91 after having opened the day at $91.14 as compared to the previous trading day's close of $90.69.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $26.5 billion and is part of the health care sector. The company has a P/E ratio of 9.7, below the S&P 500 P/E ratio of 17.7. Shares are up 48.9% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Baxter International ( BAX) is up $0.60 (0.9%) to $68.00 on light volume. Thus far, 1.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $67.40-$68.13 after having opened the day at $67.41 as compared to the previous trading day's close of $67.39.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $36.2 billion and is part of the health care sector. The company has a P/E ratio of 16.9, below the S&P 500 P/E ratio of 17.7. Shares are up 1.1% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.50 (0.7%) to $74.00 on light volume. Thus far, 1.4 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.2 million shares. The stock has ranged in price between $73.43-$74.31 after having opened the day at $73.50 as compared to the previous trading day's close of $73.50.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $73.2 billion and is part of the health care sector. The company has a P/E ratio of 13.8, below the S&P 500 P/E ratio of 17.7. Shares are up 35.5% year to date as of the close of trading on Friday. Currently there are 13 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?